SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001140361-23-037975
Filing Date
2023-08-04
Accepted
2023-08-04 08:56:21
Documents
4
Group Members
CHARLES CONNFRED COHENMONOGRAPH CAPITAL PARTNERS I GENPAR, LPMONOGRAPH CAPITAL PARTNERS I, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D brhc20056869_sc13d.htm SC 13D 170811
2 EXHIBIT 1 brhc20056869_ex1.htm EX-99.1 14320
3 EXHIBIT 2 brhc20056869_ex2.htm EX-99.2 4301
4 EXHIBIT 3 brhc20056869_ex3.htm EX-99.3 4303
  Complete submission text file 0001140361-23-037975.txt   195379
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Subject) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89992 | Film No.: 231142330
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4001 KENNETT PIKE SUITE 302 WILMINGTON DE 19807
Business Address 4001 KENNETT PIKE SUITE 302 WILMINGTON DE 19807 (208) 720-9157
Monograph Capital Holdings Advisors, LLC (Filed by) CIK: 0001988760 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D